NovaBioMed Inc

NURTURING HEALTHIER, BETTER AND HAPPIER LIVES

Home    About us    Research and Development  Drug Milestone  Technology   Business Development  Investors  Media   Career   Contact    

 

FOR INVESTORS

 
Company Profile:

NovaBioMed Inc  is a growing specialty pharmaceutical company with a unique delivery system that delivers its cancer drugs specifically to the cancer site while reducing drug toxicities and overcoming tumor multidrug resistance (MDR). Its lead candidate CERTAX® just completed a very successful preclinical studies. The company is vertically integrated and has develop environmentally friendly and efficient enabling technology for production of its active pharmaceutical ingredient (APIs).  Among the API produced, the important drug Taxol, Docetaxel and other Taxanes congeners. . 

Our pipeline has a few small molecules at various stages of development for indications in various forms of cancers. NovaBioMed Inc will enlist partners for further co-development. 

To order an investor kit or for more information, please contact  investors@novabiomed.com or:

Investor Relations Department – NovaBioMed  Inc.
Unit 12B
Kentville, Nova Scotia, Canada B4N 3V7
TEL: (902) 678-9549;
FAX: (902) 678-9545

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NovaBioMed Inc 2010